BlackRock’s TriSalus Life Sciences TLSI Stock Holding History

BlackRock’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.1M	Buy	2,659,218 +1,159,671	+77%	+$4.61M	﹤0.01%	3577
2026 Q1	$6M	Sell	1,499,547 -34,789	-2%	-$170K	﹤0.01%	3754
2025 Q4	$10.7M	Buy	1,534,336 +746,472	+95%	+$4.18M	﹤0.01%	3427
2025 Q3	$3.66M	Buy	787,864 +166,175	+27%	+$778K	﹤0.01%	3906
2025 Q2	$3.39M	Buy	621,689 +591,419	+1,954%	+$3.17M	﹤0.01%	3918
2025 Q1	$167K	Hold	30,270	–	–	﹤0.01%	4639
2024 Q4	$152K	Hold	30,270	–	–	﹤0.01%	4679
2024 Q3	$140K	Hold	30,270	–	–	﹤0.01%	4608
2024 Q2	$167K	Sell	30,270 -11,900	-28%	-$101K	﹤0.01%	4585
2024 Q1	$411K	Buy	42,170 +40,900	+3,220%	+$378K	﹤0.01%	4423
2023 Q4	$10.7K	Buy	+1,270	New	+$6.54K	﹤0.01%	5137
2022 Q4	–	Sell	-2,728,633	Closed	-$27.1M	–	5841
2022 Q3	$27.1M	Sell	2,728,633 -318	-0%	-$3.15K	﹤0.01%	2862
2022 Q2	$26.9M	Hold	2,728,951	–	–	﹤0.01%	2919
2022 Q1	$26.7M	Hold	2,728,951	–	–	﹤0.01%	2988
2021 Q4	$27M	Sell	2,728,951 -21,049	-0.8%	-$209K	﹤0.01%	3093
2021 Q3	$27.3M	Hold	2,750,000	–	–	﹤0.01%	3078
2021 Q2	$26.7M	Hold	2,750,000	–	–	﹤0.01%	3122
2021 Q1	$26.6M	Buy	+2,750,000	New	+$27.9M	﹤0.01%	3028

Other funds holding TLSI

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

BlackRock's TLSI Position: Q2 2026 in Review

BlackRock increased its TriSalus Life Sciences (TLSI) stake by 77% in Q2 2026, buying an estimated $4.61M and bringing the position to 2,659,218 shares worth $12.1M. The position accounts for ﹤0.01% of the portfolio, ranked #3577.

BlackRock first reported a position in TLSI in Q1 2021 and has held it in 18 quarters since. The position peaked at $27.3M in Q3 2021. 79 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

BlackRock held 2,659,218 shares of TriSalus Life Sciences worth $12.1M as of Q2 2026.
BlackRock bought 1,159,671 TriSalus Life Sciences shares in Q2 2026, an estimated $4.61M.
TriSalus Life Sciences made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #3577 holding.
BlackRock first reported a position in TriSalus Life Sciences in Q1 2021 and has held it in 18 quarters since.
BlackRock's TriSalus Life Sciences position peaked at $27.3M in Q3 2021.
79 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.